| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
864,930 |
| 52
Week Range: |
$191.51 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
39,326 |
484,602 |
| Total Sell Value |
$0 |
$0 |
$8,245,949 |
$88,100,996 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
18 |
70 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dobmeier Eric |
Chief Operating Officer |
• – – |
2011-12-22 |
4 |
OE |
$4.45 |
$44,500 |
D/D |
10,000 |
71,843 |
|
- |
|
| Gryska David W |
Director |
– • – |
2011-12-15 |
4 |
OE |
$5.00 |
$22,500 |
D/D |
4,500 |
19,500 |
|
- |
|
| Lippman Marc E |
Director |
– • – |
2011-12-14 |
4 |
OE |
$6.40 |
$44,000 |
D/D |
6,875 |
110,450 |
|
- |
|
| Gryska David W |
Director |
– • – |
2011-12-09 |
4 |
S |
$18.09 |
$180,917 |
D/D |
(10,000) |
15,000 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2011-12-01 |
4 |
AS |
$15.97 |
$239,597 |
D/D |
(15,000) |
1,045,055 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2011-12-01 |
4 |
OE |
$6.34 |
$95,100 |
D/D |
15,000 |
1,060,055 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2011-11-09 |
4 |
OE |
$5.25 |
$13,209 |
D/D |
2,516 |
61,843 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2011-11-01 |
4 |
AS |
$21.89 |
$328,413 |
D/D |
(15,000) |
1,045,055 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2011-11-01 |
4 |
OE |
$6.34 |
$95,100 |
D/D |
15,000 |
1,060,055 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2011-10-27 |
4 |
AS |
$21.95 |
$459,150 |
D/D |
(20,918) |
59,327 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2011-10-27 |
4 |
OE |
$5.81 |
$122,725 |
D/D |
20,918 |
70,162 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2011-10-20 |
4 |
AS |
$20.58 |
$421,024 |
D/D |
(20,461) |
59,327 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2011-10-20 |
4 |
OE |
$6.74 |
$137,907 |
D/D |
20,461 |
79,788 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2011-10-07 |
4 |
AS |
$21.97 |
$534,970 |
D/D |
(24,350) |
49,242 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2011-10-07 |
4 |
OE |
$5.20 |
$126,620 |
D/D |
24,350 |
73,592 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2011-10-04 |
4 |
AS |
$20.15 |
$302,283 |
D/D |
(15,000) |
1,045,055 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2011-10-04 |
4 |
OE |
$6.34 |
$95,100 |
D/D |
15,000 |
1,060,055 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2011-09-21 |
4 |
AS |
$20.15 |
$491,711 |
D/D |
(24,400) |
1,045,055 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2011-09-21 |
4 |
OE |
$6.34 |
$154,696 |
D/D |
24,400 |
1,069,455 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2011-09-20 |
4 |
AS |
$20.00 |
$112,007 |
D/D |
(5,600) |
1,045,055 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2011-09-20 |
4 |
OE |
$6.34 |
$35,504 |
D/D |
5,600 |
1,050,655 |
|
- |
|
| Mclaughlin John Peter |
Director |
– • – |
2011-09-09 |
4 |
OE |
$9.82 |
$245,500 |
D/D |
25,000 |
25,000 |
|
- |
|
| Baker Felix |
Director |
– • • |
2011-09-06 |
4 |
B |
$17.00 |
$30,285 |
I/I |
1,773 |
323,148 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2011-09-06 |
4 |
B |
$17.00 |
$2,206,641 |
I/I |
129,187 |
14,776,080 |
2.25 |
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2011-09-02 |
4 |
OE |
$3.30 |
$53,628 |
D/D |
16,251 |
1,045,055 |
|
- |
|
1805 Records found
|
|
Page 49 of 73 |
|
|
